The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its position within the broader market now triggers questions about potential gains. Alternative versions are eroding exclusivity , prompting worries that betting on companies heavily reliant to Viagra's former influence could be a problematic decisi